124 related articles for article (PubMed ID: 24417635)
1. Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.
Idoate MA; Echeveste J; Diez-Valle R; Lozano MD; Aristu J
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):736-46. PubMed ID: 24417635
[TBL] [Abstract][Full Text] [Related]
2. PTEN methylation and expression in glioblastomas.
Baeza N; Weller M; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2003 Nov; 106(5):479-85. PubMed ID: 12904991
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
5. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
[TBL] [Abstract][Full Text] [Related]
6. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
7. PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma.
Kato H; Fujimura M; Kumabe T; Ishioka C; Kanamaru R; Yoshimoto T
J Clin Neurosci; 2004 Jan; 11(1):37-41. PubMed ID: 14642363
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: two hits on the gene?
Hühns M; Salem T; Schneider B; Krohn M; Linnebacher M; Prall F
Oncol Rep; 2014 May; 31(5):2236-44. PubMed ID: 24647592
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of PTEN (encoding phosphate and tensin homolog) associated with elevated HER2 expression is an adverse prognostic indicator in gastric cancer.
Zaitsu Y; Oki E; Ando K; Ida S; Kimura Y; Saeki H; Morita M; Hirahashi M; Oda Y; Maehara Y
Oncology; 2015; 88(3):189-94. PubMed ID: 25472613
[TBL] [Abstract][Full Text] [Related]
11. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
Mellinghoff IK; Wang MY; Vivanco I; Haas-Kogan DA; Zhu S; Dia EQ; Lu KV; Yoshimoto K; Huang JH; Chute DJ; Riggs BL; Horvath S; Liau LM; Cavenee WK; Rao PN; Beroukhim R; Peck TC; Lee JC; Sellers WR; Stokoe D; Prados M; Cloughesy TF; Sawyers CL; Mischel PS
N Engl J Med; 2005 Nov; 353(19):2012-24. PubMed ID: 16282176
[TBL] [Abstract][Full Text] [Related]
13. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.
Fleischer M; Kessler R; Klammer A; Warnke JP; Eschrich K
Genes Chromosomes Cancer; 2011 Dec; 50(12):1010-20. PubMed ID: 21987444
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in primary glioblastomas in Japan.
Fukushima T; Favereaux A; Huang H; Shimizu T; Yonekawa Y; Nakazato Y; Ohagki H
J Neuropathol Exp Neurol; 2006 Jan; 65(1):12-8. PubMed ID: 16410744
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA alterations in primary (de novo) and secondary glioblastomas.
Kita D; Yonekawa Y; Weller M; Ohgaki H
Acta Neuropathol; 2007 Mar; 113(3):295-302. PubMed ID: 17235514
[TBL] [Abstract][Full Text] [Related]
16. Genetic pathways to glioblastoma: a population-based study.
Ohgaki H; Dessen P; Jourde B; Horstmann S; Nishikawa T; Di Patre PL; Burkhard C; Schüler D; Probst-Hensch NM; Maiorka PC; Baeza N; Pisani P; Yonekawa Y; Yasargil MG; Lütolf UM; Kleihues P
Cancer Res; 2004 Oct; 64(19):6892-9. PubMed ID: 15466178
[TBL] [Abstract][Full Text] [Related]
17. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
Lin H; Bondy ML; Langford LA; Hess KR; Delclos GL; Wu X; Chan W; Pershouse MA; Yung WK; Steck PA
Clin Cancer Res; 1998 Oct; 4(10):2447-54. PubMed ID: 9796977
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression.
Katona TM; O'Malley DP; Cheng L; Hiatt KM; Wang M; Anagnostou JJ; Billings SD; Smoller BR
Am J Surg Pathol; 2007 Oct; 31(10):1552-6. PubMed ID: 17895757
[TBL] [Abstract][Full Text] [Related]
19. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.
Kolasa IK; Rembiszewska A; Janiec-Jankowska A; Dansonka-Mieszkowska A; Lewandowska AM; Konopka B; Kupryjańczyk J
Gynecol Oncol; 2006 Nov; 103(2):692-7. PubMed ID: 16793127
[TBL] [Abstract][Full Text] [Related]
20. The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas.
Cao VT; Jung TY; Jung S; Jin SG; Moon KS; Kim IY; Kang SS; Park CS; Lee KH; Chae HJ
Neurosurgery; 2009 Nov; 65(5):866-75; discussion 875. PubMed ID: 19834398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
